OPENDOOR ($3.15) loong idea long near 3.15 and add at 2.85
sl needs to be weekly close below 2.55
small qty only ive taken
Spac
LiveWire LVW EV Motorcycle Company SPAC Blank Checkran across this in a Michael Burry article.
Transaction net proceeds of $545 million* will fund LiveWire's strategic plan to accelerate its go-to-market model, invest in new product development, and enhance global manufacturing & distribution capabilities
- LiveWire will benefit from industry-leading strategic partners - Harley-Davidson and KYMCO, a leading global powersports company headquartered in Taiwan - by leveraging their engineering expertise, manufacturing footprint, distribution, supply chain infrastructure and global logistics capabilities
- LiveWire pro forma enterprise value of approximately $1.77 billion
- Harley-Davidson and ABIC to Host a Joint Conference
SPAC: Special Acquisition to "IPO private companies"Dipping your toes into the wild "reverse IPO" SPACs....
A SPAC, Special Purpose Acquisition Company, is a company that uses its funds to transform existing private companies to list them on the Stock Market. Read up on the SEC.GOV on these "special" financial instruments from Wall Street and friends before risking a penny on these things.
We'll use a special SPAC acquiring a company very close to home: D-Wave Systems of Vancouver (Burnaby), Canada regulated under Canadian and BC Laws.
For D-Wave's IPO via XPOA (the SPAC) to QBTS ("quantum bits") this will be done on the NYSE listed. D-Wave Systems is currently private and a leader in Quantum Computing with North American headquarters and control. A former Canadian star is graduating to the US. See the company web site for details www.dwavesys.com
AI (Artificial Intelligence) is the future and "Quantum Bits" D-Wave QBTS might do very well as it becomes fully vetted in the USA via it's "big board", the NYSE (New York Stock Exchange). Everything needs "servers" and quantum computers are the big players in serving processing speeds. Check the past and recent clients for D-Wave Systems.
In this Tutorial, we'll use TradingView Charts to explaining the possible price action on this chart based on the public information available both in the US (new D-Wave Regulatory home) and Canada (existing D-Wave Regulatory home).
As a way of a background: D-Wave a leading Canadian Quantum SuperComputing is on its way to "move" from being privately held in Vancouver, Canada to being American sharesholder owned via NYSE under the expected symbol QBTS..SPACs are one way to play the IPO but it's all speculative. These are listed as
The very interesting thing with the Markets is Canada operates under its own rules and Laws. So something that might be approved in Court last week for example, is "public" in Canada but may not be advertised in the US until regulatory requirements are met in both Canada and the US. The Charts on XPOA (DCPM Capital), shows the spike in February 2022 when the acquisition was announced.
"Update: D-Wave to Go Public via Merger with SPAC DPCM Capital; DPCM Shares Rise
Feb 8, 202208:47 Reuters
D-Wave Systems, a provider of quantum computing systems, software, and services, said Tuesday that it has agreed to merge with special purpose acquisition company DPCM Capital (XPOA) to become a publicly-traded entity."
In July, the charts shows the XPOA (and associated XPOA.U and XPOA.W) was repriced and the market respected sending the SPAC from the $10s to the $7s
This is a SPAC to watch since D-Wave Systems is a large company located in Greater Vancouver, Canada. It was a Canadian technology company and will become one of the few (or only?) pure play US company in the Quantum Computing space.
There is a customary US publication ban until proper regulatory approval is received. The "may not be distributed in the United States" allows the company to get past stockholders to understand the restructuring. Track the official Public filings available from the SEC in the US. The SEC (Securities and Exchange Commission) being the regular lists any public information as filed by the company at: www.sec.gov
The Latest public news is www.sec.gov
A Shareholder vote to be voted on TOMORROW August 2nd 2022 Price action shows it has very good changes of being approved especially given the Provincial/State Canadian BC Court Approval last week which was public with restrictions on the company relating to publication in the US prior to Shareholder approval.
Interesting times...
DISCLOSURE & Liability Waiver: The above could be all wrong. FACT CHECK everything anonymous posts! BR is part of a group of Researchers of the Markets and regulatory protocols. SPACs are truly "special" (read up at SEC.GOV) and not for the novice investors. These "high growth speculative plays" need to be viewed with either deep fundamental analysis. HTA (Hybrid Technical Analysts) using certain "conditions" to determine when to jump on and off. Volume and changes in volume is one of the key indicators and mapping these to Regulatory Disclosures is interesting. For "XPOA SPAC to QBTS IPO", since this is the Study at this point given the Events, we expect Bullish volume to possibly resume here with a massive short squeeze as the dark uncertainties get cleared up tomorrow DPCM Capital/D-Wave Systems Special Shareholder Vote August 2nd 2022. Only shareholders as of June 2022 get to participate and vote at the Shareholder Meeting. Contact the company or Regulators for more information or post as a Comment if you know something public that isn't widely known. Just think I'm just an "Elf on summer break", I have no freaking idea where that Rudolf is! That "red nose" is a concern for some but it's NOT because the poor is a drunk. That's vicious rumours by bad actors! He was just born that way! Seriously, this is just an early "heads up" from "Up North", friendly neighbours. Hey!
Peace on Earth and at Home.
DWAC (Truth Social) Looks Ready To Recover (200% Potential)Truth Social SPAC DWAC looks about ready to recover.
A very strong correction took place since early March this year that resulted in a total 78.40% loss of value.
Now we are getting early signals that things are about to change.
The current price action smells to liquidity hunt.
A break below support just to quickly reverse.
As usual, bottomed out;
Very low risk with high potential rewards.
You can find the targets and stop-loss details on the chart.
Namaste.
$ENJY entry PTs .21 Next Target PTs .33-.38 and higher Long termEnjoy Technology, Inc. operates mobile retail stores in the United States, Canada, and the United Kingdom. It assists consumer in evaluating and selecting a range of accessories, media subscriptions, device protection, broadband, and other services. The company was founded in 2015 and is headquartered in Palo Alto, California.
$BTTX entry PTs 1.30-1.40 Long term PT 17-50 and higherBetter Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
$DWAC entry PTs 36.40-44.90 Next Target PTs 90-93 and higher CAPE TOWN, South Africa, July 1, 2021 /PRNewswire/ -- Leatt Corporation (OTCQB: LEAT), a developer and marketer of protective equipment and ancillary products for many forms of sports, especially extreme high-velocity sports, announced today that the Depository Trust Company ("DTC") has approved its common stock for DWAC/FAST transfers. This newly approved stock transfer capability will enable Leatt stockholders to transfer their shares of Leatt's common stock electronically after buying or selling on the open market.
Leatt CEO, Sean Macdonald, said, "DWAC/FAST approval is a part of our overall investor relations commitment to our stockholders. Leatt stockholders will benefit from the approval, which we expect will reduce the expense and delay associated with the processing and transfer of physical share certificates, eliminate the inherent risks and costs associated with the loss and replacement of physical stock certificates, and result in higher liquidity for our stockholders due to the increased accessibility and availability of shares."
About DWAC/FAST
DWAC allows participants to instruct DTC regarding deposit and withdrawal transactions being made directly via a FAST transfer agent. The FAST system eliminates the movement of physical share certificates for transfers of securities registered in the name of DTC's nominee, Cede & Co., on the transfer agent's books. DTC and its FAST transfer agents reconcile the results of participants' deposit and withdrawal activities electronically on a daily basis.
$CRXTClarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.
$BTTXBetter Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
HUB Security (TASE: HUB) Recovers Lost Ground, Braces for NASDAQ2022 has been quite the ride for Hub Security (TASE: HUB). In late January, the company announced its intention to pursue a NASDAQ listing via an unnamed SPAC merger. Further details were released on March 23rd, when HUB announced a definitive SPAC merger with RNER for a Q2/3 '22 listing on NASDAQ at a $1.3B valuation. Significantly, this market cap represents a significant valuation multiplier for existing HUB.TA shareholders, presenting a unique opportunity for significant upside for LT investors and stakeholders. After posting nearly 100% share price increase YTD, following the SPAC merger announcement HUB share value tanked, bottoming out late-March after backtracking most YTD gains. That said, in the weeks since the stock is slowly re-accruing value as some of the initial hype is fading away, signaling the re-entry of LT investors after traders/ST-holders panic-sold in March.
In sum, HUB.TA +26% YTD, meaning that it has far outperformed multiple benchmarks such as the TA90 (+3.39%), QQQ (-17.16%) and the CIBR ETF (-4.7%). As NASDAQ and really the global tech market as a whole have taken a beating, HUB continues to perform strongly and regain lost ground as it braces for its highly-anticipated NASDAQ listing. To date, price action is flirting with the 10-day MA, meaning the free-fall of end-Q1 has all about stopped. Furthermore, RSI has been moving steadily through slightly undervalued territory, meaning that now HUB share price is more fairly priced by the market compared to the burst of volatility in late-March. All tentatively bullish signs that this confidential computing disruptor is re-establishing its footing after a bump in the road as it braces to make a splash on the US cybersecurity/tech investment space.
DWAC AnalysisI have a bullish bias on this SPAC. I believe that once the merger is approved it will be a major catalyst for ticker symbol $DWAC. All that bread I will stack. I ain't gonna be living in no more lack. Getting money, run up the racks. Balling like I'm Shack. All these rhymes I just cracked. Once it squeezes, I pray I don't have a heart attack. Great dip buy opportunity IMO. Not investment advice of course.
$ISPO Next Target PTs 50-60 and higherInspirato Incorporated operates as a subscription-based luxury travel company. The company provides affluent travelers access to a managed and controlled portfolio of hand-selected vacation options. Its portfolio includes branded luxury vacation homes available exclusively to subscribers and guests. The company was founded in 2010 and is based in Denver, Colorado.
MP Materials Strong as Expected$MP made a new ATH just recently as I was/am expecting this stock to go far, however, the wave count and the indicators show that the price acceleration has taken the stock to the overvalued zone. The price can still go up if momentum traders pick up the stock and push it more towards the sky, however for long term investors the valuation is becoming rich for what it is today and I think it is time to trim a bit to lock in some profit or start to sell covered calls
MILE bouncing from all time lowRemember the pay-per-mile auto insurance company Metromile and how it went up after the SPAC merger, to 20usd?
This month MILE had the all time low, $0.85. What a drop!
But for few days it showed a little bit of strength and in a best case scenario it can touch the $3.10 resistance.
Looking forward to read your opinion about it.
$VIEWW (Warrants) Next Target PTs 1.25-2.75 and higherDescription: View Operating Corporation, a technology company, develops, manufactures, and sells smart building products. Its product portfolio includes View Smart Glass that comprise electrochromic glass panels in the form of insulating glass units; View Net, a cloud-connected network infrastructure offering that can incorporate and power smart building devices; View Immersive Experiences, which transforms View Smart Glass windows into transparent, digital, and interactive surfaces; View Sense modules to measure and optimize light, humidity, temperature, air quality, dust, and noise; and View Smart Protect, an intrusion detection solution that can be deployed on View Smart Glass windows to improve the security of a building by detecting glass breakage. The company is headquartered in Milpitas, California.
Industry: Building Products & Equipment
$GWHDescription: ESS Inc. designs, builds, and deploys iron flow batteries for commercial and utility-scale energy storage applications worldwide. The company provides energy warehouse and energy center solutions, which uses earth-abundant iron, salt, and water for the electrolyte and energy storage solutions. Its products are used for various applications, including utility scale, microgrids, distributed energy management systems, virtual power plants, and commercial and industrial organizations. The company was founded in 2011 and is headquartered in Wilsonville, Oregon.
Industry: Electrical Equipment & Parts
$EOSE Description: Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for utility, commercial and industrial, and renewable energy markets in the United States. The company offers stationary battery storage solutions. Its flagship product is the Eos Znyth DC battery system designed to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, New Jersey.
Industry: Electrical Equipment & Parts
$CLVR PT 10-19 and higherClever Leaves Holdings Inc. cultivates, extracts, manufactures, and commercializes pharmaceutical-grade cannabinoid products in Colombia, Portugal, Germany, the United States, and Canada. The company operates through two segments, Cannabinoid and Non-Cannabinoid. It also engages in the formulating, manufacturing, marketing, distributing, and selling of homeopathic and other natural remedies, wellness products, detoxification products, nutraceuticals, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors. Clever Leaves Holdings Inc. is based in New York, New York.
$PNT entry PTs 1-4 Target PT 65 and higherDescription: POINT Biopharma Global Inc., a late-stage clinical precision oncology company, focuses on the development and commercialization of radiopharmaceuticals for the treatment of cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer; and PNT-2004, a fibroblast activation protein-a targeted radioligand to treat solid tumors. POINT Biopharma Global Inc. is based in Indianapolis, Indiana.
Industry: Biotechnology
$PHGE PT 12-24 and higherDescription: BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). The company's lead product candidate BX001, which is in Phase II that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type. Its products under development include BX003 to treat acne-prone skin, IBD, and PSC; BX004, a therapeutic phage product candidate for chronic respiratory infections caused by pseudomonas aeruginosa; and BX005, a topical phage product candidate for staphylococcus aureus, a bacterium associated with the development and exacerbation of inflammation in atopic dermatitis, as well as CRC program targets strains of bacteria found in CRC tumors. The company has license agreement with Keio University and JSR Corporation to bacterial targets that are related to IBD and the phage to eradicate these bacterial targets. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Industry: Biotechnology
$GMTX (SPACs) Description: Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) and linked ocular disorders. Its lead candidate is GEM103, a recombinant form of the human complement factor H protein that is in a Phase 2a trials in dry AMD patients with a complement factor H protein risk variant. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Industry: Biotechnology
SOFI Superbowl LVI hosted on the SoFi Stadium Two weeks ago you had the chance to buy SOFI at the SPAC price of Dec 2020.
What a round trip it made!
On Sunday, Superbowl LVI is hosted on the SoFi Stadium. It looks futuristic and will drive a lot of attention to its sponsor, SoFi, the online personal finance company that paid about $625 million for a 20-year naming rights deal.
My short term price target is the $14.15 resistance, but it can easily go to $17, which is the Bank of America`s price target for SoFi.
Looking forward to read your opinion about it.
MP Material one of the best SPACs$MP has been, for sure, one of the best SPACs when it comes to performance. SPACs got hammered multiple times. Barely did some of the known ones hold the $10 ground and some of them now are traded in $2-$3 range per share if now lower. I had a very high conviction on $MP from its DA announcement and I am holding it from before the merger. Today, I see more strength given the fact that they have a good moat when it comes to rare earth material. After China, they are the biggest one in the world and practically the only one in the US. Electrification is becoming more strategic and there have been rumors that China has threatened American companies on cutting off the supply of the rare earth. This is a very strong position for $MP.
Their gross margin is not like a mining or material company, but like a tech company. This year they are projected to have an 82.10% gross margin on 446M revenue. The projection of the revenue for 2021 is 319.30M (137.7% growth compared to 2020). In 2022 the revenue growth rate is estimated to be around 40%.
EV/GP (Enterprise Value/Gross Profit) for 2022 is 15.1 and EV/GP/Growth for the same year is 38.1. It shows the price of the stock is fair. Considering the growth, the price could go lower in a short term to offer a nice opportunity to buy or add. As it can be seen on the chart after the short report released on the 3rd Feb, the price recovered relatively and today it experienced nearly 8% hike so far. This shows the interest in $MP is high. If we can get a 20% discount from these levels to around 30s before the 24th Feb (2021 Q4 earning release) I believe it is a good level to start collecting or adding. This is not financial advice. DYODD
